News and Trends 12 Jun 2023
Beacon Therapeutics launches with $120M to develop gene therapies for retinal diseases
Beacon Therapeutics Holdings Limited has been launched to develop gene therapies to treat a range of rare and prevalent retinal diseases that result in blindness. Syncona Limited, with additional investors…